Found: 11
Select item for more details and to access through your institution.
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 471, doi. 10.1007/s12094-021-02716-4
- By:
- Publication type:
- Article
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 460, doi. 10.1007/s12094-021-02715-5
- By:
- Publication type:
- Article
Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 556, doi. 10.1007/s12094-021-02714-6
- By:
- Publication type:
- Article
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 446, doi. 10.1007/s12094-021-02712-8
- By:
- Publication type:
- Article
Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case–control study.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 540, doi. 10.1007/s12094-021-02711-9
- By:
- Publication type:
- Article
Low-dose radiation therapy for hand osteoarthritis: shaking hands again?
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 532, doi. 10.1007/s12094-021-02710-w
- By:
- Publication type:
- Article
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 432, doi. 10.1007/s12094-021-02709-3
- By:
- Publication type:
- Article
MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt/β-catenin signaling.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 546, doi. 10.1007/s12094-021-02713-7
- By:
- Publication type:
- Article
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 407, doi. 10.1007/s12094-021-02707-5
- By:
- Publication type:
- Article
Circulating exosomal miRNAs and cancer early diagnosis.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 393, doi. 10.1007/s12094-021-02706-6
- By:
- Publication type:
- Article
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 483, doi. 10.1007/s12094-021-02708-4
- By:
- Publication type:
- Article